AMY BAKER: Open Payments
NPI 1043663396 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,075 in 55 payments from 20 companies in 2025. Trend: 2023 $1,244 · 2024 $1,563 · 2025 $1,075
Food & beverage: $1,075
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $183 |
| ABBVIE INC. | 8 | $147 |
| Abbott Laboratories | 4 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Medtronic, Inc. | 1 | $71 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| SHIELD THERAPEUTICS INC | 1 | $52 |
| Amgen Inc. | 3 | $47 |
| Boston Scientific Corporation | 1 | $32 |
Products named: Ozempic, FREESTYLE LIBRE 3, VRAYLAR, CAPLYTA, Wegovy, VENASEAL, REXULTI, AIRSUPRA.
Industry payments across KS — which companies pay providers there.
